Literature DB >> 8420133

Striatal dopaminoceptive system changes and motor response complications in L-dopa-treated patients with advanced Parkinson's disease.

T N Chase1, T M Engber, M M Mouradian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8420133

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  4 in total

1.  Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.

Authors:  Krystof S Bankiewicz; Marcel Daadi; Philip Pivirotto; John Bringas; Laura Sanftner; Janet Cunningham; John R Forsayeth; Jamie L Eberling
Journal:  Exp Neurol       Date:  2005-12-09       Impact factor: 5.330

2.  L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.

Authors:  Jennifer M King; Gladson Muthian; Veronica Mackey; Marquitta Smith; Clivel Charlton
Journal:  Life Sci       Date:  2011-08-18       Impact factor: 5.037

3.  Administration of FGF-1 through transfected cells alleviates MPTP toxicity in mice.

Authors:  R N McLay; S M Freeman; J E Zadina
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

4.  Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.

Authors:  Agnieszka Ciesielska; Nitasha Sharma; Janine Beyer; John Forsayeth; Krystof Bankiewicz
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.